Literature DB >> 9249508

Newborn piglet cerebral microvascular responses to epoxyeicosatrienoic acids.

C W Leffler1, A L Fedinec.   

Abstract

The present study on the newborn pig cerebral microcirculation determined the vasoactive properties of epoxyeicosatrienoic acids (EETs) and the contributions of prostaglandin cyclooxygenase to these properties. Pial arterioles of anesthetized piglets were observed through closed cranial windows, EETs were applied topically, and artificial cerebrospinal fluid from beneath the cranial windows was collected for the determination of adenosine 3',5'-cyclic monophosphate and 6-ketoprostaglandin F1 alpha. EETs caused dilation of pial arterioles and increased adenosine 3',5'-cyclic monophosphate. 5,6-EET produced a dose-dependent dilation at 10(-8) M and above, whereas 10(-6) M was required for 8,9-EET, 11,12-EET, and 14,15-EET. Indomethacin abolished pial arteriolar dilation to the EETs. However, EETs did not increase cortical 6-ketoprostaglandin F1 alpha concentration. Treatment of indomethacin-treated piglets with iloprost (10(-12) M topically) restored dilation to 5,6-EET. Neither isoproterenol nor sodium nitroprusside allowed vasodilation to 5,6-EET in indomethacin-treated piglets. Therefore, in the newborn pig cerebral microvasculature. EETs are potent vasodilators and prostacyclin-receptor agonists are necessary to allow this dilation to occur.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9249508     DOI: 10.1152/ajpheart.1997.273.1.H333

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

Review 1.  Potassium channels and neurovascular coupling.

Authors:  Kathryn M Dunn; Mark T Nelson
Journal:  Circ J       Date:  2010-03-16       Impact factor: 2.993

2.  An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats.

Authors:  Anne M Dorrance; Nicole Rupp; David M Pollock; John W Newman; Bruce D Hammock; John D Imig
Journal:  J Cardiovasc Pharmacol       Date:  2005-12       Impact factor: 3.105

3.  Onset of pulmonary ventilation in fetal sheep produces pial arteriolar constriction dependent on cytochrome p450 omega-hydroxylase activity.

Authors:  Hiroto Ohata; Debebe Gebremedhin; Jayashree Narayanan; David R Harder; Raymond C Koehler
Journal:  J Appl Physiol (1985)       Date:  2010-05-20

Review 4.  Epoxides and soluble epoxide hydrolase in cardiovascular physiology.

Authors:  John D Imig
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

Review 5.  Epoxygenase metabolites. Epithelial and vascular actions.

Authors:  J D Imig
Journal:  Mol Biotechnol       Date:  2000-11       Impact factor: 2.695

6.  20-Hydroxyeicosatetraenoic Acid Inhibition by HET0016 Offers Neuroprotection, Decreases Edema, and Increases Cortical Cerebral Blood Flow in a Pediatric Asphyxial Cardiac Arrest Model in Rats.

Authors:  Jafar Sadik B Shaik; Samuel M Poloyac; Patrick M Kochanek; Henry Alexander; Dana L Tudorascu; Robert Sb Clark; Mioara D Manole
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-10       Impact factor: 6.200

Review 7.  Vascular pharmacology of epoxyeicosatrienoic acids.

Authors:  Sandra L Pfister; Kathryn M Gauthier; William B Campbell
Journal:  Adv Pharmacol       Date:  2010

Review 8.  Role of astrocytes in cerebrovascular regulation.

Authors:  Raymond C Koehler; Debebe Gebremedhin; David R Harder
Journal:  J Appl Physiol (1985)       Date:  2006-01

9.  Role of gap junctions and EETs in endothelium-dependent hyperpolarization of porcine coronary artery.

Authors:  G Edwards; C Thollon; M J Gardener; M Félétou; J Vilaine; P M Vanhoutte; A H Weston
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

10.  Interaction of nitric oxide, 20-HETE, and EETs during functional hyperemia in whisker barrel cortex.

Authors:  Xiaoguang Liu; Chunyuan Li; John R Falck; Richard J Roman; David R Harder; Raymond C Koehler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-23       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.